Factor XII Tenri, a novel cross-reacting material negative factor XII deficiency, occurs through a proteasome-mediated degradation

Blood

Volumn 93, Issue 12, 1999, Pages 4300-4308

  Kondo, Shinichi ^b   Tokunaga, Fuminori ^b   Kawano, Seiji ^b   Oono, Yoichi ^b   Kumagai, Shunichi ^b   Koide, Takehiko ^a  

^a UNIVERSITY OF HYOGO   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 MICROGLOBULIN; BLOOD CLOTTING FACTOR 12; PROTEASOME;

ADULT; AMINO ACID SUBSTITUTION; AMINO TERMINAL SEQUENCE; ARTICLE; BLOOD CLOTTING FACTOR 12 DEFICIENCY; CASE REPORT; DNA FLANKING REGION; ENDOPLASMIC RETICULUM; EXON; HUMAN; MALE; MISSENSE MUTATION; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN SECRETION; RESTRICTION SITE;

EID: 0033564909     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v93.12.4300.412k01_4300_4308     Document Type: Article

References (43)

1. Fujikawa K, Davie EW: Human factor XII (Hageman factor). Methods Enzymol 80:198, 1981
2. Pixley RA, Colman RW: Human factor XII: Hageman factor. Methods Enzymol 222:51, 1993
3. McMullen BA, Fujikawa K: Amino acid sequence of the heavy chain of human α-factor XIIa (activated Hageman factor). J Biol Chem 260:5328, 1985
4. Cool DE, Edgell CJ, Louie GV, Zoller MJ, Brayer GD MacGillivray RT: Characterization of human blood coagulation factor XII cDNA. Prediction of the primary structure of factor XII and the tertiary structure of β-factor XIIa. J Biol Chem 260:13666, 1985
5. Que BG, Davie EW: Characterization of a cDNA coding for human factor XII (Hageman factor). Biochemistry 25:1525, 1986
6. Cool DE, MacGillivray RT: Characterization of the human blood coagulation factor XII gene: Intron/exon gene organization and analysis of the 5′-flanking region. J Biol Chem 262:13662, 1987
7. Fujikawa K, Kurachi K, Davie EW: Characterization of bovine factor XIIa (activated Hageman factor). Biochemistry 16:4182, 1977
8. Ratnoff OD, Colopy JE: Familial hemorrhagic trait associated with deficiency of clot-promoting fraction of plasma. J Clin Invest 34:602, 1955
9. Saito H: Contact factors in health and disease. Semin Thromb Hemost 13:36, 1987
10. Schloesser M, Hofferbert S, Bartz U, Lutze G, Lammle B, Engel W: The novel acceptor splice site mutation 11396(G→A) in the factor XII gene causes a truncated transcript in cross-reacting material negative patients. Hum Mol Genet 4:1235, 1995
11. Bernardi F, Marchetti G, Patracchini P, del Senno L, Tripodi M, Fantoni A, Bartolai S, Vannini F, Felloni L, Rossi L, Panicucchi F, Conconi F: Factor XII gene alteration in Hageman trait detected by TaqI restriction enzyme. Blood 69:1421, 1987
12. Hofferbert S, Muller J, Kostering H, von Ohlen WD, Schloesser M: A novel 5'-upstream mutation in the factor XII gene is associated with a TaqI restriction site in an Alu repeat in factor XII-deficient patients. Hum Genet 97:838, 1996
13. Miyata T, Kawabata S, Iwanaga S, Takahashi I, Alving B, Saito H: Coagulation factor XII (Hageman factor) Washington D.C.: Inactive factor XIIa results from Cys-571→Ser substitution. Proc Natl Acad Sci USA 86:8319, 1989
14. Hovinga JK, Schaller J, Snicker H, Wuillemin WA, Furlan M, Lammle B: Coagulation factor XII Locarno: The functional defect is caused by the amino acid substitution Arg 353→Pro leading to loss of a kallikrein cleavage site. Blood 84:1173, 1994
15. Schloesser M, Zeerleder S, Lutze G, Halbmayer WM, Hofferbert S, Hinney B, Koestering H, Lammle B, Pindur G, Thies K, Kohler M, Engel W: Mutations in the human factor XII gene. Blood 90:3967, 1997
16. Kanaji T, Okamura T, Kamura T, Niho Y, Sugiyama M: Molecular analysis of a family with factor XII deficiency. Identification of 126 Arg to Pro substitution. Blood 86:876a, 1995 (abstr)
17. Kanaji T, Okamura T, Osaki K, Kuroiwa M, Shimoda K, Hamasaki N, Niho Y: A common genetic polymorphism (46C to T substitution) in the 5′-untranslated region of the coagulation factor XII gene is associated with low translation efficiency and decrease in plasma factor XII level. Blood 91:2010, 1998
18. 577), with susceptibility to Sjögren's syndrome. Arthritis Rheum 40:1685, 1997
19. Schägger H, von Jagow G: Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa. Anal Biochem 166:368, 1987
20. Kondo S, Tokunaga F, Kario K, Matsuo T, Koide T: Molecular and cellular basis for type 1 heparin cofactor II deficiency (heparin cofactor II Awaji). Blood 87:1006, 1996
21. Chen C, Okayama H: High-efficiency transformation of mammalian cells by plasmid DNA. Mol Cell Biol 7:2745, 1987
22. Tokunaga F, Wakabayashi S, Koide T: Warfarin causes the degradation of protein C precursor in the endoplasmic reticulum. Biochemistry 34:1163, 1995
23. Tokunaga F, Tsukamoto T, Koide T: Cellular basis for protein C deficiency caused by a single amino acid substitution at Arg15 in the y-carboxyglutamic acid domain. J Biochem (Tokyo) 120:360, 1996
24. 1-microglobulin and the inability to form a calcium-induced conformation. Biochem J 311:753, 1995
25. 1-microglobulin. Thromb Haemost 75:70, 1996
26. Misumi Y, Misumi Y, Miki K, Takatsuki A, Tarawa G, Ikehara Y: Novel blockade by brefeldin A of intracellular transport of secretory proteins in cultured rat hepatocytes. J Biol Chem 261:11398, 1986
27. Lippincott-Schwartz J, Yuan LC, Bonifacino JS, Klausner RD: Rapid redistribution of Golgi proteins into the ER in cells treated with brefeldin A: Evidence for membrane cycling from Golgi to ER. Cell 56:801, 1989
28. Seglen PO, Grinde B, Solheim AE: Inhibition of the lysosomal pathway of protein degradation in isolated rat hepatocytes by ammonia, methylamine, chloroquine and leupeptin. Eur J Biochem 95:215, 1979
29. Thorens, B, Vassalli P: Chloroquine and ammonium chloride prevent terminal glycosylation of immunoglobulins in plasma cells without affecting secretion. Nature 321:5, 1986
30. Tsubuki S, Saito Y, Tomioka M, Ito H, Kawashima S: Differential inhibition of calpain and proteasome activities by peptidyl aldehydes of di-leucine and tri-leucine. J Biochem (Tokyo) 119:572, 1996
31. Tanaka K: Proteasome: Structure and biology. J Biochem (Tokyo) 123:195, 1998
32. Fenteany G, Standaert RF, Lane WS, Choi S, Corey EJ, Schreiber SL: Inhibition of proteasome activities and subunit-specific amino-terminal threonine modification by lactacystin. Science 268:726, 1995
33. 1-microglobulin. Trends Biochem Sci 15:240, 1990
34. 1-microglobulin. Nucleic Acids Res 14:7839, 1986
35. Steinmann C, Bogli C, Jungo M, Lammle B, Heinemann G, Wermuth B, Redaelli R, Baudo F, Furlan M: A new substitution, γ358Ser→Cys, in fibrinogen Milano VII causes defective fibrin polymerization. Blood 84:1874, 1994
36. Karnura T, Tsuda H, Yae Y, Hattori S, Ohga S, Shibata Y, Kawabata S, Hamasaki N: An abnormal fibrinogen Fukuoka II (GlyBβ15→Cys) characterized by defective fibrin lateral association and mixed disulfide formation. J Biol Chem 270:29392, 1995
37. Terukina S, Matsuda M, Hirata H, Takeda Y, Miyata T, Takao T, Shimonishi Y: Substitution of γArg-275 by Cys in an abnormal fibrinogen, "fibrinogen Osaka II". Evidence for a unique solitary cysteine structure at the mutation site. J Biol Chem 263:13579, 1988
38. Koide T, Odani S, Takahashi K, Ono T, Sakuragawa N: Antithrombin III Toyama: Replacement of arginine-47 by cysteine in hereditary abnormal antithrombin III that lacks heparin-binding ability. Proc Natl Acad Sci USA 81:289, 1984
39. Odani S, Koide T, Ono T, Aoyagi Y: Analysis of strongly acidic amino acids by the conventional amino acid analyzer: Application to determination of protein-bound cysteine and glutathione. Anal Biochem 171:305, 1988
40. Kopito RR: ER quality control: The cytoplasmic connection. Cell 88:427, 1997
41. Kim PS, Arvan P: Endocrinopathies in the family of endoplasmic reticulum (ER) storage diseases: Disorders of protein trafficking and the role of ER molecular chaperones. Endocrine Rev 19:173, 1998
42. Tokunaga F, Shirotani H, Hara K, Kozuki D, Omura S, Koide T: Intracellular degradation of secretion defect-type mutants of antithrombin is inhibited by proteasomal inhibitors. FEBS Lett 412:65, 1997
43. Helenius A, Trombetta ES, Hebert DN, Simons JF: Calnexin, calreticulin and folding of glycoproteins. Trends Cell Biol 7:193, 1997